Sell Bio-Techne (TECH) stock to fund a goal
Calculator · free · no signup · TECHNeed cash for a goal? Plan the minimum-tax schedule to sell your vested Bio-Techne (TECH) shares and net a target amount by a target date, across tax years.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Inputs
Your equity
One stack per ticker (current-employer RSUs, prior-employer holdings, index fund, etc.). Each stack has its own current price, growth assumption, and cost-basis lots.
Drives chance-of-shortfall · default 30%
Lots
Plan
Estimates only. Not financial advice.
Lock-in-now is deterministic (0%). Plans that wait depend on future prices; risk is near-zero when inventory comfortably exceeds the goal. Volatility: each stack's option-implied vol if a ticker is set, otherwise 30%. Lognormal model; real markets have fatter tails.
| Tax | $109,597 | $111,639 | $111,883 | $118,769 |
| Wealth @ target | $719,068 | $716,894 | $714,464 | $712,031 |
| Chance of shortfall | <0.1% | 0% | 1.9% | 3.4% |
Feasible
$400,071 net by 08/01/27
Total tax: $109,597 (federal $58,819, state $36,048, NIIT $14,729)
Schedule · Recommended
| Sale date | Shares | Tax | Net | Cumulative |
|---|---|---|---|---|
| 08/17/26 | 4,085 | $351,104 | $360,043 | |
| 03/31/27 | 4 | $360 | $360,406 | |
| 04/30/27 | 32 | $2,896 | $363,321 | |
| 05/31/27 | 100 | $9,103 | $372,466 | |
| 06/30/27 | 100 | $9,157 | $381,644 | |
| 07/31/27 | 100 | $9,212 | $390,857 | |
| 08/01/27 | 100 | $9,215 | $400,071 |
Risk vs wealth
Each dot is a possible plan. Right is riskier, up is more wealth left over.
Trajectory of cash netted
Solid line = expected. Shaded band = 10th–90th percentile under price uncertainty.
After the plan
You keep 3,479 shares worth $411,873 at the projected target-date price, invested for the next decision.
You solved for a cash target. The beta optimizes your full portfolio across multiple goals and market scenarios, not just one funding need.
Request beta access →Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator · RSU Sell-vs-Hold Calculator
About Bio-Techne
Bio-Techne (TECH) is a public Other company, incorporated in Minnesota and headquartered in Minneapolis, MN.
Equity grants at Bio-Techne typically include restricted stock units (RSUs).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Source: Wikipedia (CC BY-SA 4.0)
The company was Techne Corporation, whose R&D Systems division began selling research proteins and antibodies from Minneapolis in 1976, and it renamed itself in 2014. Products are reagents used in laboratory experiments: cytokines, antibodies, assay kits, and increasingly instruments for protein analysis through the ProteinSimple line. Acquisitions added cell and gene therapy manufacturing inputs and spatial biology tools. Academic and biotech research budgets drive demand, and the consumable nature of the products makes revenue recurring without subscriptions.
Sources: bio-techne.com · en.wikipedia.org
Equity comp at Bio-Techne
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Bio-Techne.
If you hold vested Bio-Techne (TECH) shares and need a set amount of cash by a date (a house down payment, tuition, a sabbatical, a business buy-in), the question is which lots to sell and in which tax years to keep the most after tax. This calculator builds the minimum-tax sell schedule across your lots, accounting for federal long-term capital gains, the net investment income tax, and your state.
All Bio-Techne tools → · Use the generic Stock Sale Funding Calculator for any company.
Bio-Techne equity questions
- How much TECH stock do I sell to fund a goal without overpaying tax?
- It depends on your cost basis, your target amount and date, and how the sale spreads across tax years. Selling vested TECH shares triggers long-term capital-gains tax, plus the 3.8% net investment income tax and state tax above certain income, and bunching a large sale into one year can push the gain into a higher bracket. The calculator above builds the minimum-tax sell schedule across your lots to net your target amount by your date.
- Does Bio-Techne grant ISOs, NSOs, or RSUs?
- Equity compensation at Bio-Techne typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Bio-Techne RSUs use double-trigger vesting?
- No. Bio-Techne restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyOther peers
- RiverNorth Long Prime Unicorn Fund I, Inc.PublicOpen →
- RiverNorth Short Prime Unicorn Fund I, IncPublicOpen →
- Global X FundsPublicOpen →
- Accenture (ACN)PublicOpen →
- Cognizant (CTSH)PublicOpen →
- Globant (GLOB)PublicOpen →
- DXC Technology (DXC)PublicOpen →
- Eli Lilly (LLY)PublicOpen →
- Pfizer (PFE)PublicOpen →
- Merck (MRK)PublicOpen →
One piece of the puzzle.
OptionsAhoy plans your Bio-Techne equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.